In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) closed at $2.02 down -2.42% from its previous closing price of $2.07. In other words, the price has decreased by -$2.42 from its previous closing price. On the day, 1.19 million shares were traded. MRVI stock price reached its highest trading level at $2.035 during the session, while it also had its lowest trading level at $1.99.
Ratios:
For a deeper understanding of Maravai LifeSciences Holdings Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.65 and its Current Ratio is at 7.53. In the meantime, Its Debt-to-Equity ratio is 1.16 whereas as Long-Term Debt/Eq ratio is at 1.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on February 26, 2025, Downgraded its rating to Neutral and sets its target price to $3 from $9 previously.
Goldman Downgraded its Neutral to Sell on December 05, 2024, while the target price for the stock was maintained at $4.25.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 31 ’25 when ORESHACK KURT sold 25,000 shares for $5.03 per share. The transaction valued at 125,750 led to the insider holds 167,618 shares of the business.
ORESHACK KURT bought 25,000 shares of MRVI for $125,750 on Jan 31 ’25. On Nov 12 ’24, another insider, DeFord John A, who serves as the Director of the company, bought 17,500 shares for $5.75 each. As a result, the insider paid 100,625 and bolstered with 70,046 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRVI now has a Market Capitalization of 737958528 and an Enterprise Value of 593575104. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.98 while its Price-to-Book (P/B) ratio in mrq is 0.88. Its current Enterprise Value per Revenue stands at 2.29 whereas that against EBITDA is -24.427.
Stock Price History:
The Beta on a monthly basis for MRVI is 0.18, which has changed by -0.7704545 over the last 52 weeks, in comparison to a change of 0.09969199 over the same period for the S&P500. Over the past 52 weeks, MRVI has reached a high of $11.56, while it has fallen to a 52-week low of $1.66. The 50-Day Moving Average of the stock is -17.93%, while the 200-Day Moving Average is calculated to be -65.62%.
Shares Statistics:
For the past three months, MRVI has traded an average of 3.35M shares per day and 1739760 over the past ten days. A total of 141.98M shares are outstanding, with a floating share count of 117.02M. Insiders hold about 18.71% of the company’s shares, while institutions hold 85.69% stake in the company. Shares short for MRVI as of 1744675200 were 13951884 with a Short Ratio of 4.17, compared to 1741910400 on 11604523. Therefore, it implies a Short% of Shares Outstanding of 13951884 and a Short% of Float of 11.53.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
